Ionis Announced Collaboration With AstraZeneca to Develop and Commercialize Eplontersen; Ionis to Receive $200M Upfront, Up to $485M in Development and Approval Milestones, Up to $2.9B in Sales-related Milestone Payments

by | Dec 7, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.